Natural History of Primary Biliary Cholangitis in the Ursodeoxycholic Acid Era Role of Scoring Systems

被引：31
|
作者：
Goel, Aparna [1 ]
Kim, Woong Ray [1 ]
机构：
[1] Stanford Univ, Div Gastroenterol & Hepatol, Alway Bldg,Room M211,300 Pasteur Dr, Stanford, CA 94305 USA
来源：
CLINICS IN LIVER DISEASE | 2018年 / 22卷 / 03期
关键词：
PBC; Ursodeoxycholic acid; Prognosis; Scoring systems; Predictive models; RANDOMIZED CONTROLLED-TRIALS; EARLY BIOCHEMICAL RESPONSE; LONG-TERM PROGNOSIS; DOUBLE-BLIND; HISTOLOGICAL PROGRESSION; TREATED PATIENTS; END-POINTS; FOLLOW-UP; CIRRHOSIS; SURVIVAL;
D O I：
10.1016/j.cld.2018.03.007
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Primary biliary cholangitis (PBC) is a chronic disease that progresses to end-stage liver disease. Ursodeoxycholic acid (UDCA), the standard treatment for PBC for several decades, is associated with improved survival without liver transplant. Approximately 40% of patients do not respond to UDCA. Because of disease variability, there exist several prognostic models that incorporate various factors including biochemical response to UDCA. These models are useful for patient care and counseling as well as risk stratification for research and clinical trials, and the role of these models in the pre-UDCA and UDCA eras is discussed.
引用
收藏
页码：563 / +
页数：17
相关论文
共 50 条
  • [31] Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy
    Lammers, Willem J.
    Hirschfield, Gideon M.
    Corpechot, Christophe
    Nevens, Frederik
    Lindor, Keith D.
    Janssen, Harry L. A.
    Floreani, Annarosa
    Ponsioen, Cyriel Y.
    Mayo, Marlyn J.
    Invernizzi, Pietro
    Battezzati, Pier M.
    Pares, Albert
    Burroughs, Andrew K.
    Mason, Andrew L.
    Kowdley, Kris V.
    Kumagi, Teru
    Harms, Maren H.
    Trivedi, Palak J.
    Poupon, Raoul
    Cheung, Angela
    Lleo, Ana
    Caballeria, Llorenc
    Hansen, Bettina E.
    van Buuren, Henk R.
    GASTROENTEROLOGY, 2015, 149 (07) : 1804 - +
  • [32] Efficacy and Safety of Bezafibrate Alone or in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis
    Khakoo, Nidah Shabbir
    Sultan, Shahnaz
    Reynolds, John M.
    Levy, Cynthia
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (04) : 1559 - 1573
  • [33] Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators
    Qian, Jian-Dan
    Yao, Tian-Tian
    Wang, Yan
    Wang, Gui-Qiang
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2020, 44 (06) : 874 - 884
  • [34] Features, prognosis and management of primary biliary cirrhosis in the era of ursodeoxycholic acid
    Poupon, R.
    Chazouilleres, O.
    Chretien, Y.
    Corpechot, C.
    BILE ACID BIOLOGY AND THERAPEUTIC ACTIONS, 2009, 165 : 277 - 285
  • [35] Evidence for the association between IgG-antimitochondrial antibody and biochemical response to ursodeoxycholic acid treatment in primary biliary cholangitis
    Tang, Libo
    Zhong, Ruihua
    He, Xuanqiu
    Wang, Weibin
    Liu, Jinhong
    Zhu, Youfu
    Li, Yongyin
    Hou, Jinlin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (03) : 659 - 666
  • [36] Editorial: scoring systems in primary biliary cholangitis - time to make a move
    Mells, G. F.
    Jones, D. E.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (08) : 1163 - 1164
  • [37] Treatment response in primary biliary cholangitis: The role of autoimmune hepatitis features
    Mane, Fernando
    Cardoso, Helder
    Liberal, Rodrigo
    Lopes, Susana
    Pereira, Pedro
    Goncalves, Regina
    Macedo, Guilherme
    ANNALS OF HEPATOLOGY, 2019, 18 (03) : 488 - 493
  • [38] Obeticholic acid in primary biliary cholangitis
    Erlinger, Serge
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2017, 41 (01) : 3 - 5
  • [39] Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit
    Schattenberg, Joern M.
    GUT, 2020, 69 (08) : 1377 - 1378
  • [40] Treatment of primary biliary cholangitis ursodeoxycholic acid non-responders: A systematic review
    Suraweera, Duminda
    Rahal, Harman
    Jimenez, Melissa
    Viramontes, Matthew
    Choi, Gina
    Saab, Sammy
    LIVER INTERNATIONAL, 2017, 37 (12) : 1877 - 1886
12345